Cannula needles are used to access fistula and grafts for hemodialysis patients in the U.S.. Our detailed analysis focused on decision makers, key market drivers, pricing, reimbursement guidelines, distribution channel, and product education.
We found strong interest in the marketplace as the medical device protected the healthcare provider from accidental needle sticks, reduced discomfort during dialysis, and eliminated infiltration.
We suggested adoption of the fistula catheter and consultatative selling to the dialysis center managers to show how increased patient comfort would result in more patient visits and revenues for the dialysis center.
Medical Device adoption takes time
The Medicare system in the U.S. reimburses a dialysis provider a set fee for each patient visit and not each medical device used. The use of fistula catheters will grow as providers experience increased patient interest and requests. Click link to learn more about Primary Impact's medical device industry practice.
